PortfoliosLab logoPortfoliosLab logo
GH vs. IONQ
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

GH vs. IONQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Guardant Health, Inc. (GH) and IonQ, Inc. (IONQ). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

GH vs. IONQ - Yearly Performance Comparison


2026 (YTD)20252024202320222021
GH
Guardant Health, Inc.
-9.57%234.34%12.94%-0.55%-72.81%-21.27%
IONQ
IonQ, Inc.
-35.75%7.42%237.13%259.13%-79.34%54.63%

Fundamentals

Market Cap

GH:

$11.88B

IONQ:

$10.64B

EPS

GH:

-$3.30

IONQ:

-$1.67

PS Ratio

GH:

11.85

IONQ:

67.59

Total Revenue (TTM)

GH:

$982.02M

IONQ:

$130.02M

Gross Profit (TTM)

GH:

$633.01M

IONQ:

$52.53M

EBITDA (TTM)

GH:

-$375.72M

IONQ:

-$429.34M

Returns By Period

In the year-to-date period, GH achieves a -9.57% return, which is significantly higher than IONQ's -35.75% return.


GH

1D
7.16%
1M
-1.63%
YTD
-9.57%
6M
47.84%
1Y
116.83%
3Y*
57.95%
5Y*
-10.06%
10Y*

IONQ

1D
8.42%
1M
-24.86%
YTD
-35.75%
6M
-53.12%
1Y
30.63%
3Y*
67.36%
5Y*
22.22%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GH vs. IONQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GH
GH Risk / Return Rank: 9090
Overall Rank
GH Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
GH Sortino Ratio Rank: 9191
Sortino Ratio Rank
GH Omega Ratio Rank: 8888
Omega Ratio Rank
GH Calmar Ratio Rank: 9191
Calmar Ratio Rank
GH Martin Ratio Rank: 8989
Martin Ratio Rank

IONQ
IONQ Risk / Return Rank: 5656
Overall Rank
IONQ Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
IONQ Sortino Ratio Rank: 6363
Sortino Ratio Rank
IONQ Omega Ratio Rank: 5757
Omega Ratio Rank
IONQ Calmar Ratio Rank: 5252
Calmar Ratio Rank
IONQ Martin Ratio Rank: 5252
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GH vs. IONQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Guardant Health, Inc. (GH) and IonQ, Inc. (IONQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GHIONQDifference

Sharpe ratio

Return per unit of total volatility

2.05

0.32

+1.73

Sortino ratio

Return per unit of downside risk

2.91

1.26

+1.65

Omega ratio

Gain probability vs. loss probability

1.36

1.14

+0.22

Calmar ratio

Return relative to maximum drawdown

3.97

0.39

+3.59

Martin ratio

Return relative to average drawdown

9.89

0.80

+9.09

GH vs. IONQ - Sharpe Ratio Comparison

The current GH Sharpe Ratio is 2.05, which is higher than the IONQ Sharpe Ratio of 0.32. The chart below compares the historical Sharpe Ratios of GH and IONQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


GHIONQDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.05

0.32

+1.73

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.15

0.23

-0.38

Sharpe Ratio (All Time)

Calculated using the full available price history

0.22

0.21

+0.01

Correlation

The correlation between GH and IONQ is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

GH vs. IONQ - Dividend Comparison

Neither GH nor IONQ has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

GH vs. IONQ - Drawdown Comparison

The maximum GH drawdown since its inception was -91.03%, roughly equal to the maximum IONQ drawdown of -90.00%. Use the drawdown chart below to compare losses from any high point for GH and IONQ.


Loading graphics...

Drawdown Indicators


GHIONQDifference

Max Drawdown

Largest peak-to-trough decline

-91.03%

-90.00%

-1.03%

Max Drawdown (1Y)

Largest decline over 1 year

-28.73%

-67.61%

+38.88%

Max Drawdown (5Y)

Largest decline over 5 years

-90.30%

-90.00%

-0.30%

Current Drawdown

Current decline from peak

-48.43%

-64.88%

+16.45%

Average Drawdown

Average peak-to-trough decline

-51.83%

-51.36%

-0.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.54%

32.67%

-21.13%

Volatility

GH vs. IONQ - Volatility Comparison

The current volatility for Guardant Health, Inc. (GH) is 12.82%, while IonQ, Inc. (IONQ) has a volatility of 16.38%. This indicates that GH experiences smaller price fluctuations and is considered to be less risky than IONQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


GHIONQDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.82%

16.38%

-3.56%

Volatility (6M)

Calculated over the trailing 6-month period

40.43%

66.45%

-26.02%

Volatility (1Y)

Calculated over the trailing 1-year period

57.26%

96.73%

-39.47%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

67.05%

98.06%

-31.01%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

68.17%

96.99%

-28.82%

Financials

GH vs. IONQ - Financials Comparison

This section allows you to compare key financial metrics between Guardant Health, Inc. and IonQ, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
281.27M
61.89M
(GH) Total Revenue
(IONQ) Total Revenue
Values in USD except per share items